Comparing the current results to its competitors, The Greater Cannabis Inc reported Revenue decrease in the 2 quarter 2026 year on year by 0 %, slower than the combined decrease of the GCAN's competitors by -4.58 %, recorded in the same quarter.
The Greater Cannabis Company Inc achieved net profit of $0.61 millions compared to a net loss of $-0.39 millions recorded in the same quarter a year ago.
The Greater Cannabis Inc 's Comment on Competition and Industry Peers
The competitive landscape in the cannabis sector includes companies involved in cannabis cultivation, production of cannabis-based edible products, and development of various cannabis delivery methods. Notable competitors mentioned are Jazz Pharmaceuticals and Zynerba Pharmaceuticals.
Publicly Traded Peers of The Greater Cannabis Company Inc
Kaya Holdings Inc Share Performance
0.00%
This Quarter
Kaya Holdings Inc
Profile
Kaya Holdings Inc's business model revolves around operating and franchising legal cannabis retail stores under the Smoke Shop brand. Their focus is on offering a diverse range of cannabis products, accessories, and services to cater to the needs of consumers in states where marijuana is legalized.
Igc Pharma Inc's business model revolves around the development and commercialization of innovative therapeutics derived from cannabis-based compounds. The company focuses on researching treatments for indications such as epilepsy, pain, and inflammation. Igc Pharma Inc primarily operates in the pharmaceutical industry, aiming to provide safe and effective alternatives to conventional medicines.
Fsd Pharma Inc's business model is centered around the development and production of pharmaceutical-grade cannabis products. The company aims to leverage its in-house cultivation facility, research and development capabilities, and strategic partnerships to create innovative cannabis-based therapies for various medical conditions. Fsd Pharma focuses on pursuing licensing and acquisition opportunities to expand its presence in the global cannabis market.
Earth Science Tech Inc is a biotechnology company focused on developing and marketing innovative hemp cannabinoid-based products. Their business model revolves around research, development, manufacturing, and distribution of high-quality CBD and nutraceuticals for various industries, including the pharmaceutical and nutrition sectors.
Cv Sciences Inc operates through a business model focused on the production and sale of cannabidiol (CBD) based products. The company sources hemp for extraction, processes it into various CBD products, and distributes them through multiple channels, including online sales and retail partnerships. By leveraging the growing demand for CBD, Cv Sciences Inc aims to generate revenue and establish a market presence in the emerging health and wellness industry.
Sources:
The Greater Cannabis Company Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on The Greater Cannabis Company Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
